CVE-2017-12720An Improper Access Control issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6.
Updated under an hour ago ()
Does this affect you?
It affects smiths-medical medfusion_4000_wireless_syringe_infusion_pump. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 1.85%, higher than 79% of scored CVEs.
Do this next
Free account, 1 product
An Improper Access Control issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The FTP server on the pump does not require authentication if the pump is configured to allow FTP connections.
- CVSS
- 8.1 HIGH (v3.0, NVD)CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 1.85% (percentile 79)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Aug 5, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
smiths-medical medfusion_4000_wireless_syringe_infusion_pump smiths-medical:medfusion_4000_wireless_syringe_infusion_pump | 1.1; 1.5; 1.6 | NVD |
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02Ax-refsource-misc, third-party-advisory, us-government-resource
- http://www.securityfocus.com/bid/100665vdb-entry, x-refsource-bid, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.